In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Hoechst negotiates acquisition of Marion Merrell Dow, $7 bn

Executive Summary

Making its long-anticipated direct move into the US branded drug market, Hoechst has offered Marion Merrell Dow shareholders $25.75 per share for the 71%-owned Dow Chemical unit's 278 million outstanding shares, valuing the deal at $7.16 billion.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition

Related Companies